Search

Minoxidil may be in short supply. Here are 5 other hair loss treatments you can use instead.
Adam Friedman, MD, Professor & Chair of Dermatology, is featured in an article for alternatives to Minoxidil for hair growth range from prescription medications like Finasteride to natural supplements like rosemary oil. For more information please click here.
Monitoring Immunotherapy Toxicities in CSCC and BCC
Dr. Vishal Anil Patel, MD, Director of Cutaneous Oncology and Dermatologic Surgery, is featured in an article emphasizing the role of coordinated care between dermatologists and oncologists in monitoring and managing adverse events related to immunotherapy in CSCC and BCC. For more information,…
A Phase II Study of the Safety, Tolerability and Antitumor Activity of Tucatinib in Combination With Eribulin and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer
Primary Outcome Measure: • To assess the safety and tolerability of tucatinib in combination with eribulin and trastuzumab in patients with unresectable or recurrent metastatic HER2+ breast cancer who have had prior treatment with trastuzumab, and trastuzumab deruxtecan. • Evaluate the relative…
Amarendra K. Neppalli, MD
Amarendra Neppalli, MD is a board-certified hematologist and associate professor at the GW School of Medicine and Health Sciences. He is also the chief of plasma cell disorders and director of transplant and cellular therapy at The GW Medical Faculty Associates. Dr. Neppalli takes care of patients…
A Phase 3 Randomized Study Comparing Talquetamab SC in Combination With Daratumumab SC and Pomalidomide (Tal-DP) or Talquetamab SC in Combination With Daratumumab SC (Tal-D) Versus Daratumumab SC, Pomalidomide and Dexamethasone (DPd)
Primary Outcome Measure: • Progression-Free Survival (PFS) o Time Frame: Up to 6 years 6 months
Victoria Vinarsky, DO
Victoria Vinarsky, DO is clinical instructor of Neurology at the George Washington University. Dr. Vinarsky earned her bachelor’s degree in Psychology (2008) from the University of Wisconsin-Madison.
Shahzad Ahmad, MD
Pavani Chalasani, MD, MPH
Pavani Chalasani, MD completed her medical school at Gandhi Medical College in India and completed her Internship, Residency and Fellowship in Hematology-Oncology at the University of Arizona, Tucson. Dr.
Phase 1 Study of Intratumoral Administration of VAX014 in Subjects With Advanced Solid Tumors
Phase 1 Study of Intratumoral Administration of VAX014 in Subjects With Advanced Solid Tumors
Alexandra Eid, MD
Alexandra Eid, MD is an Assistant Professor of Neurology at the George Washington University. She is board-certified in Neurology, Epilepsy and Clinical Neurophysiology. Dr.